查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球色譜系統市場 - 2023-2030
市場調查報告書
商品編碼
1374774

全球色譜系統市場 - 2023-2030

Global Chromatography Systems Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

多年來，全球色譜系統市場經歷了顯著的成長和轉變，影響其動態的因素有很多。稱為色譜法的純化系統能夠從複雜的混合物中分離出特定的物質。基於樣品和固定相之間的相互作用，發生分離。

政府的投資和研究，特別是在發展中經濟體，將繼續推動先進系統或耗材的利用，並推動全球色譜系統市場。相應的創新色譜有多種類型，例如液體色譜、氣相色譜或柱色譜。

市場動態：促進因素與限制因素

不斷成長的合作和收購

在高投資、收入水準和基礎設施發展的推動下，已開發經濟體的醫療保健產業不斷改善。由於研究的不斷增加，一些國家對色譜系統的需求很大。不同國家之間的各種合作、收購和技術進步的產品發布將是推動市場成長的關鍵因素。

2023 年 6 月 5 日，為了鞏固先前在上游生物加工分析方面的合作，沃特世公司與 Sartorius 建立了新的合作夥伴關係，為下游生物製造創建整合分析產品。由於涉及沃特世 PATROL 超高效液相層析 (UPLC) 製程評估系統以及 Sartorius Resolute BioSMB 多柱色譜平台的軟體和硬體整合，生物製程工程師將能夠獲得更全面的下游批量和連續生產分析資料。這將提高產量，同時減少浪費並降低生物製造成本。

此外，2022 年 2 月 8 日，經美國聯邦貿易委員會批准，生物製藥領域的知名合作夥伴 Sartorius Stedim Biotech 完成了對 Novasep 色譜部門的收購。收購的產品組合包括用於連續生產生物製劑的尖端設備以及最適合較小生物分子（包括寡核苷酸、勝肽和胰島素）的色譜系統。

此外，擴大利用新技術和不同類型的系統來實現多種研究目的。慢性疾病的增加和創新診斷產品開發研究的增加將是推動色譜系統市場成長的主要因素。

與色譜系統相關的高成本

系統有多種類型，它們都依賴相同的元素來產生可靠的結果。然而，由於成本高昂，許多實驗室可能很難負擔這種設備。雖然考慮到可用資金，直接購買全新或二手的液相層析系統可能不可行，但以合理的成本租賃機器是一個不錯的選擇。

液相層析設備的購買價格為 10,000 至 30,000 美元。用於更複雜的液相層析系統（包括自動進樣器、高壓泵和檢測模組）的成本可能在 40,000 美元到超過 100,000 美元之間。這些系統擁有大量設備、昂貴的感測器和複雜的內部機械裝置。這些系統有一個基本價格，但它們的運作和維護成本也很高。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按產品類型分類
  • 按模態分類
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 不斷成長的合作和收購
      • 不斷進步的技術進步與發展
    • 限制
      • 與色譜系統相關的限制
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • SWOT分析
  • 專利分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按產品類型

  • 系統
    • 液相層析系統
      • 超高效液相層析系統
      • 高效液相層析系統
      • 中壓液相層析系統
      • 其他
    • 氣相層析系統
      • 氣相層析 (GLC)
      • 氣固色譜 (GSC)
    • 薄層色譜法
      • 高壓薄層層析 (HPTLC)
      • 薄層色譜質譜法
    • 離子色譜法
    • 其他
  • 耗材
  • 軟體

第 8 章：按形態

  • 免洗系統
  • 多用途系統

第 9 章：按應用

  • 藥物和臨床測試
  • 食品與飲品
  • 環保及化工業
  • 法證學
  • 石油
  • 其他

第 10 章：最終用戶

  • 製藥公司
  • 生物技術和生命科學公司
  • 診斷中心
  • 其他

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Bio-Rad Laboratories, Inc.
  • Cytiva
  • Agilent Technologies Inc.
  • Bruker
  • PerkinElmer Inc.
  • Merck KGaA
  • Sartorius AG
  • Shimadzu Corporation
  • Waters Corporation

第 14 章：附錄

簡介目錄
Product Code: BT7173

Overview

The global chromatography systems market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. Systems for purification called chromatography enable the separation of particular substances from complicated mixtures. Based on interactions between the sample and stationary phase, separation takes place.

Government investments and research, particularly in developing economies, will continue to drive utilization of advanced systems or consumables and boost the global chromatography systems market. The respective innovative chromatography are in various types such as liquid, gas or column chromatography.

Market Dynamics: Drivers & Restraints

Growing collaborations and acquisitions

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for chromatography systems owing to the rising research. Various collaborations, acquisitions and product launches with technological advanecments among different countries will be a crucial factor driving the growth of the market.

On June 5, 2023, in order to build on their prior collaboration on upstream bioprocessing analytics, Waters Corporation with Sartorius established a new partnership to create integrated analytical products for downstream biomanufacturing. Bioprocess engineers will have access to more thorough analytical data for downstream batch and continuous manufacturing thanks to software and hardware integrations involving the PATROL UltraPerformance Liquid Chromatography (UPLC) Process Evaluation System of Waters as well as the Sartorius Resolute BioSMB multi-column chromatography platform. This will increase yields while decreasing waste and lowering biomanufacturing costs.

Additionally, on February 8, 2022, following the U.S. Federal Trade Commission's permission, Sartorius Stedim Biotech, a prominent partner in the biopharma sector, completed its purchase of the Novasep chromatography division. The portfolio that was acquired includes cutting-edge equipment for the continuous production of biologics as well as chromatography systems that are best suited for smaller biomolecules including oligonucleotides, peptides, and insulin.

Furthermore, the rising utilization of novel technology and different types of systems for the several research purposes. Rising chronic disorders and increasing research for innovative diagnostic product development will be a major factor driving the growth of the chromatography systems market.

High cost associated with the chromatography systems

There are several kinds of systems, and they all depend on the same elements to produce reliable outcomes. However, many laboratories may find it difficult to afford this equipment because of its high cost. While outright acquisition of a brand-new or used liquid chromatography system may not be viable given the available funds, leasing the machinery at a reasonable cost is a great choice.

Equipment for liquid chromatography can be purchased for anywhere between $10,000 and $30,000. Systems for more sophisticated liquid chromatography that include autosamplers, high-pressure pumps, and detection modules can cost anywhere between $40,000 to more than $100,000. These systems have substantial equipment, pricey sensors, and intricate internal mechanics. These systems have a base price, but they can also be expensive to operate and maintain.

Segment Analysis

The global chromatography systems market is segmented based on product type, modality, application, end user and region.

Systems segment accounted for approximately 54% of market share

Chromatography systems include with all the tools necessary for separating samples, a power source, and programming software. Chromatography systems are used in all biotechnology fields, from little research labs to enormous manufacturing facilities. For separation, various technologies are available.

The chemical and physical characteristics of the substance, such as chemical reactivity, size, mass, and form, as well as laboratory needs, including flow process, validation requirements, and sample tracking, must all be taken into account when choosing a chromatography system. With the use of mass spectrometry equipment, liquid and gas chromatography can be used to identify unknown compounds, as well as to ascertain the isotopic makeup of the elements in a molecule and to ascertain the compounds structure by watching its fragmentation.

June 12, 2023, Agilent Technologies Inc. will present their greatly enhanced InfinityLab GPC/SEC System at the HPLC 2023 conference. The recent acquisition of Polymer Standard Service Ltd. (PSS) by Agilent has resulted in the addition of value-added components to the portfolio of InfinityLab GPC/SEC solutions for advanced material characterization, including a Multi-Angle Light Scattering Detector, an exclusive GPC/SEC Column Thermostat, the GPC/SEC-Ready Kit, along with the potent WinGPC Software.

Geographical Penetration

North America accounted for around 34% of market share in 2022

Due to the rising need for chromatography systems in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for chromatography systems.

Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or biotechnology business establishment across the region are also contributing to the growth of chromatography systems market share of this region. The market in this area is growing as people become more aware of various novel innovative systems. The aforementioned elements further attest to North America's hegemonic position in the world.

North America continues to be a key player in the global chromatography systems market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for chromatography systems in the U.S. United States have been proactive in executing several initiatives or researches, stimulating chromatography systems demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global chromatography systems market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.

Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for chromatography systems. Now several research studies have been initiated and companies have again started trial for their products efficiency. Overall, the impact of the pandemic on the global chromatography systems market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like multiple-use systems.

Key Developments

  • On June 5, 2023, The Agilent Revident LC/Q-TOF and the Agilent 6495D LC/TQ are two new liquid chromatography mass spectrometry (LCMS) systems from Agilent Technologies Inc. Agilent also introduced the new Agilent ChemVista library manager software and the new Agilent MassHunter Explorer Profiling software, enabling the high-end capabilities of the Revident LC/Q-TOF.
  • On June 29, 2022, Low-Pressure Prepacked EconoFit Chromatography Column Packs were introduced by Bio-Rad Laboratories, Inc., a pioneer in life science investigation and clinical diagnostic products, to help resin screening tests in the creation of protein purification workflows.

Competitive Landscape

The major global players in the market include: Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Cytiva, Agilent Technologies Inc., Bruker, PerkinElmer Inc., Merck KGaA, Sartorius AG, Shimadzu Corporation and Waters Corporation.

Why Purchase the Report?

  • To visualize the global chromatography systems market segmentation based on product type, modality, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of chromatography systems market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global gene prediction tool market report would provide approximately 69 tables, 70 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Modality
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing collaborations and acquisitions
      • 4.1.1.2. Rising technological advancements and developments
    • 4.1.2. Restraints
      • 4.1.2.1. Limitations associated with the chromatography systems
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. SWOT Analysis
  • 5.6. Patent Analysis
  • 5.7. Russia-Ukraine War Impact Analysis
  • 5.8. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Systems*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Liquid Chromatography Systems
      • 7.2.3.1. Ultra High Performance Liquid Chromatography Systems
      • 7.2.3.2. High Performance Liquid Chromatography Systems
      • 7.2.3.3. Medium Pressure Liquid Chromatography Systems
      • 7.2.3.4. Others
    • 7.2.4. Gas Chromatography Systems
      • 7.2.4.1. Gas-Liquid Chromatography (GLC)
      • 7.2.4.2. Gas-Solid Chromatography (GSC)
    • 7.2.5. Thin Layer Chromatography
      • 7.2.5.1. High Pressure Thin Layer Chromatography (HPTLC)
      • 7.2.5.2. Thin Layer Chromatography Mass Spectrometry
    • 7.2.6. Ion Chromatography
    • 7.2.7. Others
  • 7.3. Consumables
  • 7.4. Software

8. By Modality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.1.2. Market Attractiveness Index, By Modality
  • 8.2. Single-use Systems*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Multiple-use Systems

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Drug and Clinical Testing *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Food and Beverage
  • 9.4. Environmental and Chemical Industry
  • 9.5. Forensics
  • 9.6. Petroleum
  • 9.7. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Pharmaceutical Companies*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Biotechnology and Life Science Companies
  • 10.4. Diagnostic Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Thermo Fisher Scientific Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Bio-Rad Laboratories, Inc.
  • 13.3. Cytiva
  • 13.4. Agilent Technologies Inc.
  • 13.5. Bruker
  • 13.6. PerkinElmer Inc.
  • 13.7. Merck KGaA
  • 13.8. Sartorius AG
  • 13.9. Shimadzu Corporation
  • 13.10. Waters Corporation

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us